vet3-tgi
kalivir
['vet3-tgi']
kalivir s co-founder and cso stephen thorne is at #aacr23 presenting a poster on new in vivo data demonstrating potent therapeutic activity for our lead candidate, vet3-tgi. stop by and see what he s showcasing! read more here: 
KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment.